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Abstract
Without a virus culture system, genetic analysis becomes the principal method to classify norovirus (NoV) strains. Currently, classification of
NoV strains beneath the species level has been based on sequences from different regions of the viral genome. As a result, the phylogenetic
insights of some virus were not appropriately interpreted, and no consensus has been reached to establish a uniform classification scheme. To
provide a consistent and reliable scientific basis for classifying NoVs, we analyzed the amino acid sequences for the major capsid protein of 164
NoV strains by first using an alignment based on the predicted 3D structures. A Bayesian tree was generated, and the maximum likelihood
pairwise distances of the aligned sequences were used to evaluate the results from the uncorrected pairwise distance method. Analyses of the
pairwise distances demonstrated three clearly resolved peaks, suggesting that NoV strains beneath the species level can be classified at three
levels: strain (S), cluster (C), and genogroup (G). The uncorrected pairwise distance ranges for S, C, and G were 0–14.1%, 14.3–43.8%, and
44.9–61.4%, respectively. A scheme with 29 genetic clusters [8 in genogroup 1 (G1), 17 in G2, 2 in G3, and 1 each in G4 and G5] was defined on
the basis of the tree topology with the standards provided and was supported by the distance analysis. Of these, five clusters in G2 and one in G1
are newly described. This analysis can serve as the basis for a standardized nomenclature to genetically describe NoV strains.
D 2005 Elsevier Inc. All rights reserved.
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Gastroenteritis is a major public health problem worldwide.
With the application of new and sensitive diagnostic techni-
ques, noroviruses (NoVs) are now recognized as the leading
cause of outbreaks and cases of nonbacterial, acute gastroen-
teritis in humans. Up to 93% of these outbreaks and 60–85%
of all gastroenteritis outbreaks within the United States,
Europe, and Japan are associated with NoVs (Fankhauser et
al., 2002; Inouye et al., 2000; Lopman et al., 2003). From 1997
to 2000, 233 outbreaks of gastroenteritis were reported to the
Centers for Disease Control and Prevention (CDC); 86% (N =
201) were laboratory-confirmed to be associated with NoV
(Fankhauser et al., 2002). NoV outbreaks occur in many
settings, such as nursing homes, restaurants, schools, hospitals,
and cruise ships (Fankhauser et al., 2002; Glass et al., 2000;
Green et al., 2002; Widdowson et al., 2004). The viruses are
very contagious and infect persons of all ages who consume
contaminated food or water or who have close contact with
infected persons (Rockx et al., 2002). Volunteer studies
indicate that immunity to NoVs seems to be short lived and
that immunity to one strain does not provide good protection
from infection with other heterogeneous strains (Johnson et al.,
1990; Matsui and Greenberg, 2000; Parrino et al., 1977; Wyatt
et al., 1974). Observations of repeat infections in adults also
suggest that long-term immunity may be absent (Fankhauser
et al., 2002; Rockx et al., 2002). Recent studies indicate that
susceptibility to NoV infection is associated with ABH histo-
blood types, gut-expressed carbohydrates, and strain prefer-
ences (Harrington et al., 2004; Hutson et al., 2004; Meyer
et al., 2004; Tan et al., 2004). No vaccine is currently available
to prevent NoV disease in humans (Estes et al., 2000).
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Noroviruses (formerly called ‘‘Norwalk-like viruses’’),
which were discovered in 1972 (Dolin et al., 1972; Kapikian
et al., 1972), belong to the genus Norovirus in the family
Caliciviridae (Green et al., 2000a; van Regenmortel et al.,
2000). The viral genome is a plus-sense, single-stranded RNA
of ¨7.5 kb that contains three open reading frames (ORFs).
ORF1 encodes the nonstructural polyprotein that is cleaved by
viral 3C-like protease into probably 6 proteins, including the
deduced RNA-dependent RNA polymerase [RdRp] (Belliot et
al., 2003). ORF2 and ORF3 encode the major (VP1) and minor
(VP2) capsid proteins, respectively (Green et al., 2001; Jiang et
al., 1990, 1993). The VP1 protein forms two domains: P
(protruding, P1 and P2) and S (shell). Most of the cellular
interactions and immune recognition features are thought to be
located in the P2 sub-domain, which extends above the viral
surface and has the most sequence divergence in the genome
(Chakravarty et al., 2005; Nilsson et al., 2003; Prasad et al.,
1999; Tan et al., 2004). Therefore, it is believed that the capsid
protein not only provides shell structure for the virus but also
contains cellular receptor binding site(s) and viral phenotype or
serotype determinants. The function of VP2 associates with up-
regulation of VP1 expression in cis and stabilization of VP1 in
the virus structure (Bertolotti-Ciarlet et al., 2003).
NoVs are genetically and antigenically diverse (Ando et al.,
2000; Green et al., 1995, 1997, 2000b; Katayama et al., 2002).
Historically, classification of NoVs was based on cross-
challenge studies in volunteers and cross-reactivity analysis
by immune electron microscopy (Green et al., 1995; Lewis
et al., 1995; Okada et al., 1990; Wyatt et al., 1974). These
antigenic classification schemes had poor accuracy and
reproducibility, which were attributed to the cross-reactivity
of antibodies (Ando et al., 2000). Direct serotyping based on
neutralization is not possible because no cell culture system has
been established for growing this virus (Duizer et al., 2004).
Consequently, reverse transcription-polymerase chain reaction
(RT-PCR) and genomic sequencing have become the major
means for characterizing the viruses and to understand the
relatedness of different strains (Ando et al., 2000; Jiang et al.,
1990, 1993; Katayama et al., 2002). Accumulated sequence
information has been especially useful for viral diagnosis and
genotyping, and most investigators have chosen primers from
conserved regions, such as the RdRp gene, in order to detect
the greatest number of these diverse strains. The targeted
regions are called region A (the RdRp gene located in ORF1),
region B (the 3V-end of ORF1), region C (a short stretch close
to the 5V-end of ORF2), and region D (located at the 3V-end of
ORF2) (Ando et al., 2000; Vinje´ et al., 2004). The region D
primers were found to work well for detection of GI and GII
viruses and to be suitable for strain differentiation; however, no
evaluation has yet been based on the complete capsid
sequences, and no clear criteria have been created for NoV
classification. Short conserved sequences have been used
successfully for NoV detection, especially when applied to
multiplex PCR or real-time PCR (Kageyama et al., 2003;
Richards et al., 2004; Yan et al., 2003), but such sequences
become problematic for phylogenetic analyses because, with
limited sequence variations, some strains cannot be distin-
guished from each other or be accurately classified into their
proper clusters (Fankhauser et al., 2002; Kageyama et al.,
2004).
Five genogroups (G) of NoVs have been tentatively
assigned from the molecular characterization of complete
capsid gene sequences (Fankhauser et al., 2002; Green et al.,
1995; Karst et al., 2003; Oliver et al., 2003; Vinje´ and
Koopmans, 2000). Strains of three genogroups, GI, GII, and
GIV, are found in humans (GII/11 are porcine), and GIII and
GV strains are found in cows and mice, respectively. However,
no consensus has been reached concerning the classification of
NoV stains within genogroups. Few studies have examined
complete capsid sequences for phylogenetic studies, and none
has included sequences from all five genogroups. An early
study of 35 NoV capsid sequences identified 7 sub-genogroups
within GI and 8 sub-genogroups within GII (Green et al.,
2000b). A later study of 39 capsid sequences from human
NoVs classified these strains into 23 different genetic clusters
(7 in GI, 15 in GII, and 1 in GIV) (Vinje´ et al., 2004).
Nevertheless, 14 genotypes in GI and 17 genotypes in GII,
based on partial capsid and RdRp sequences (Kageyama et al.,
2004), and 7 genetic clusters in GI, 8 plus 3 unassigned clusters
in GII, and 1 cluster each in GIII and GIV, based only on partial
capsid sequences of region C (Fankhauser et al., 2002), have
been described.
To avoid confusion and to provide clear criteria for
classification of NoVs and a consistent reliable basis for
NoV nomenclature, we analyzed 164 deduced amino acid (AA)
sequences of the NoV major capsid protein, including all
sequences from five genogroups available at the time of the
study. A well-defined phylogenetic scheme of NoVs was
established, and strain clustering was evaluated by multiple
methods of distance calculation. From our results, we propose
an updated classification scheme for standardization of NoV
nomenclature, which should aid molecular characterization and
description of outbreak strains and provide genetic insights for
future studies with this virus.
Results
Sequences and structure-based alignment
Of the 273 sequences obtained from GenBank by use of a
BLAST search, only 145 met our criteria for study inclusion;
an additional 19 new sequences were added from the CDC
collection (Table 1). From the preliminary phylogenetic
analysis of the 164 sequences (data not shown), 43 were
chosen (including 1 or 2 from each of the major branches) to
represent the diversity of NoV strains in this collection and
used to construct an initial 3D structural alignment. The
smaller number of the 43 sequences was aligned spatially first
to avoid complexity during the structural modeling caused by
limitations of computer memory and software handling. This
structure-based alignment then served as a frame for aligning
all of the 164 sequences. Overall, we created three structure-
based alignments: (1) the 164-sequence alignment, 164-Cap,
which included all available complete capsid sequences; (2)
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the 141-sequence alignment, 141-Cap(d), in which any
columns with gaps were removed and 23 sequences in the
164-Cap alignment were no longer unique and were excluded;
and (3) the 68-sequence alignment, 68 Cap(d), which was
derived from the 141-Cap(d) in which only a prototype and
1–2 reference strain sequences (if available) from each cluster
were selected.
Phylogenetic relationships and classification of NoVs
To avoid a bias by presenting results with incomplete data
and to reflect the diversity of currently available NoV
sequences, we constructed a consensus Bayesian tree, using
the 141-Cap(d) alignment that contained all available unique
complete capsid sequences (Fig. 1). The tree consists of five
Table 1
NoV sequences used for this study
G_Cluster Name Source G_Cluster Name Source G_Cluster Name Source
G1_1 NV-USA93 M87661 G2_3 SU18-JPN AB039781 G2_6 SU3-JPN AB039776
G1_1 Wtchest-USA AY502016 G2_3 MG312-USA AF414413 G2_6 SU4-JPN AB039777
G1_1 KY89-JPN L23828 G2_3 BB321-USA AF414415 G2_6 SU17-JPN AB039779
G1_1 Aich124-JPN AB031013 G2_3 Mexico1-MEX U22498 G2_6 BT274-USA AF414408
G1_2 WR96-GBR AJ277610 G2_3 OTH25-USA L23830 G2_6 SU16-JPN AB039778
G1_2 FB258-JPN AB078335 G2_3 LV247-USA AF414411 G2_6 UENO7k-JPN AB078337
G1_2 SOV-GBR93 L07418 G2_4 Bristol-GBR93 X76716 G2_6 FL269-USA AF414407
G1_2 C59-USA AF435807 G2_4 Lsdale-GBR X86557 G2_6 Seacrof-GBR00 AJ277620
G1_3 PD196-DEU AF439267 G2_4 VA98387-USA AY038600 G2_6 Miami292-USA AF414410
G1_3 LR316-USA AF414405 G2_4 CBW94-AUS AF145896 G2_7 GN273-USA AF414409
G1_3 DSV-USA93 U04469 G2_4 MD145-USA AY032605 G2_7 Leeds-GBR00 AJ277608
G1_3 Stav-NOR99 AF145709 G2_4 DG259-DEU AF425766 G2_8 SU25-JPN AB039780
G1_3 HLL219-USA AF414403 G2_4 NT104-JPN AB078336 G2_8 Amstdam-NLD99 AF195848
G1_3 VA98115-USA AY038598 G2_4 MD1347-USA AY030098 G2_9 Idafall-USA AY054299
G1_4 Chiba-JPN00 AB042808 G2_4 FL408-USA AF080558 G2_9 VABeach-USA01 AY038599
G1_4 Koblenz-DEU AF394960 G2_4 Mora97-SWE AY081134 G2_10 Erfurt-DEU01 AF427118
G1_4 Valetta-MLT AJ277616 G2_4 AZ379-USA AF080556 G2_11 SW918-JPN01 AB074893
G1_4 BTM277-USA AF414404 G2_4 FL384-USA AF080557 G2_11 SWVA34-USA AY077644
G1_4 Leed92-GBR AJ313030 G2_4 ID366-USA AF080554 G2_11 SW43-JPN AB074892
G1_4 NO266-USA AF414402 G2_4 DJ171-FRA AF472623 G2_12 U1GII-JPN AB067536
G1_5 SzUG1-JPN AB039774 G2_4 OC112-DEU AF427113 G2_12 SU1-JPN AB039775
G1_5 Musgrov-GBR00 AJ277614 G2_4 95M14-AUS AF080551 G2_12 GIFU96-JPN AB045603
G1_5 AB318-USA AF414406 G2_4 SC373-USA AF080555 G2_12 SCH003-DEU AF397905
G1_6 Hesse-DEU98 AF093797 G2_4 AZ364-USA AF080553 G2_12 Chitta-JPN AB032758
G1_6 WUG1-JPN AB081723 G2_4 FL358-USA AF080552 G2_12 HLL314-USA AF414420
G1_6 Wiscon-USA AY502008 G2_4 LA416-USA AF080559 G2_12 Pirna110-DEU AF427119
G1_6 CS841-USA AY502007 G2_4 BL495-DEU AF427123 G2_12 Wortley-GBR00 AJ277618
G1_6 VA497-USA AF538678 G2_4 SC345-USA AF080549 G2_13 Faytvil-USA02 AY113106
G1_7 Wnchest-GBR00 AJ277609 G2_4 AK140-DEU AF425765 G2_13 KSW47-JPN AB078334
G1_8 Boxer-USA02 AF538679 G2_4 BK124-DEU AF427120 G2_14 M7-USA03 AY130761
G2_1 WO302-USA AF414418 G2_4 BL159-DEU AF425763 G2_15 Mex7076-USA AF542090
G2_1 Hawaii-USA94 U07611 G2_4 LS218-DEU AF427115 G2_15 J23-USA02 AY130762
G2_1 Miami81-USA AF414416 G2_4 DG4770-AUS AF406793 G2_16 Tonto-USA AY502005
G2_1 DG391-DEU AF425767 G2_4 EF007-DEU AF427117 G2_16 Fayett-USA AY502014
G2_1 RM283-USA AF414419 G2_4 BL491-DEU AF427122 G2_16 Fairfd-USA AY502013
G2_1 PC301-USA AF414421 G2_4 Oder170-DEU AF427114 G2_16 Sandsk-USA AY502012
G2_1 WD294-DEU AF425769 G2_4 SG95-GBR AJ277619 G2_16 Canton-USA AY502011
G2_2 Msham-GBR95 X81879 G2_4 SC3452-USA AF080550 G2_16 Tiffin-USA03 AY502010
G2_2 CF434-USA AY054300 G2_4 BLD331-USA AF414425 G2_16 Hiram-USA AY502006
G2_2 SMV1-USA AY134748 G2_4 LS221-DEU AF427116 G2_16 Bradhe-USA AY502015
G2_2 SMV2-USA U70059 G2_4 MB326-USA AF414424 G2_17 CSE1-USA03 AY502009
G2_3 NLV1157-SWE AY247439 G2_4 BL238-DEU AF425764 G3_1 BoJena-DEU98 AJ011099
G2_3 NLV2004-SWE AY247432 G2_4 UK317-GBR AF414417 G3_2 BoNA2-GBR AF097917
G2_3 HB385-DEU AF539439 G2_4 KO130-DEU AF427121 G3_2 BoCV95-USA AF542083
G2_3 OH455-DEU AF539440 G2_4 FMHill-USA AY502023 G3_2 BoCV186-USA AF542084
G2_3 MD102-USA AY030312 G2_4 CSG4-USA AY502022 G3_2 BoPR55-GBR AY126476
G2_3 MD1341-USA AY030313 G2_4 CSG2-USA AY502021 G3_2 BoDF94-GBR AY126474
G2_3 AL96-NZL U46039 G2_4 CSG1-USA AY502020 G3_2 BoCH131-NLD AF320113
G2_3 BB289-DEU AF427112 G2_4 Anchor-USA AY502019 G3_2 BoCH126-NLD00 AF320625
G2_3 Toronto-CAN93 U02030 G2_4 CSD1-CAN AY502018 G3_2 BoAS24-GBR AY126475
G2_3 ARG320-USA AF190817 G2_4 Germtn-USA AY502017 G4_1 Alphatn-NLD99 AF195847
G2_3 NO279-USA AF414412 G2_5 MOH99-HUN AF397156 G4_1 FLD560-USA AF414426
G2_3 SU201-JPN AB039782 G2_5 NO306-USA AF414422 G4_1 SCD624-USA AF414427
G2_3 TS313-USA AF414414 G2_5 Hilingd-GBR00 AJ277607 G4_1 Murine1-USA03 AY228235
G2_3 RBH93-GBR AJ277617 G2_5 WR290-USA AF414423
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Fig. 1. Phylogenetic analysis of complete capsid AA sequences of 141 NoV strains. The tree was constructed with the structural alignment of 141 NoV sequences (column gaps removed) by using MrBayes program
(Huelsenbeck et al., 2001). Tree topology was evaluated on the base of 1,000,000 generations (posterior possibility, 1.00 equals 100% out of 1,000,000). Formats of sequence name: Name–Country code (reference
strains); Name–Country code Year (two digits) (prototype strains [in bold]). Number in square box is the cluster number within the genogroup (G). Country codes: AUS, Australia; CAN, Canada; DEU, Germany;
FRA, France; HUN, Hungary; JPN, Japan; MLT, Malta; MEX, Mexico; NLD, Netherlands; NZL, New Zealand; NOR, Norway; SWE, Sweden; GBR, the United Kingdom; USA, the United States.
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well-separated clades, each containing prototype strain(s) of the
genogroups defined in this or earlier studies (Fankhauser et al.,
2002; Green et al., 1995; Karst et al., 2003; Oliver et al., 2003;
Vinje´ and Koopmans, 2000). On the basis of the tree’s
topology and supported by the posterior probability of 1.00
for all branch partitions, these five clades were designated as
genogroups GI–GV (Fig. 1). The two largest clades, GI and
GII, include most of the diverse and common NoVs and are
segregated into 8 clusters for GI and 17 clusters for GII.
Consecutive numbers were assigned to each cluster, using
method described previously (Ando et al., 2000) and on the
basis of clusters already defined (Fankhauser et al., 2002; Vinje´
et al., 2004). Among them, 1 cluster (GI/8) in GI genogroup
and 5 clusters (GII/13–17) in GII genogroup were newly
described or defined. Three previously unassigned clusters,
based upon analysis of partial capsid sequence information,
GII/j, GII/m, and GII/n (Fankhauser et al., 2002), were resolved
and assigned as GII/13, GII/16, and GII/10, respectively. All
sequences in GI and GII were from human viruses, with an
exception of those in GII/11 that were from porcine viruses.
Another genogroup of human strains, GIV, currently has only a
single cluster. Two genogroups of NoVs of bovine (GIII) and
murine (GV) origin have 2 and 1 clusters, respectively. All
clusters in this classification scheme were well resolved with
no intermediate clusters or genogroups found, and they were
supported by the robust posterior probability (1.00, similar to
bootstrapping 100%). In addition, we observed that tree
topologies obtained from the analyses based on structural
and nonstructural alignments remained the same (data not
shown), and the classification scheme was consistent with
results from our earlier work (Ando et al., 2000; Fankhauser
et al., 2002).
Pairwise distance distribution of NoV sequences
Pairwise distances between sequences were calculated using
either uncorrected or ML distances. To access the results
obtained from the analysis using the uncorrected distance
method (a common and conservative method) and to evaluate
the classification scheme defined above (Fig. 1), we used the
more reliable ML distance method for calculation of pairwise
distances for 141 unique AA sequences. Numbers in the distance
matrix obtained from ML distance analysis (data not shown)
were plotted into a histogram that yielded three major peaks
(indicated as S, C, andG) corresponding to the distance ranges of
strains, clusters, and genogroups, respectively (Fig. 2A). These
Fig. 2. Pairwise distance distribution of NoV strains. Pairwise distances of strains (S), clusters (C), and genogroups (G) were calculated by using (A) maximum
likelihood (ML) method with 141-Cap (d) sequence alignment; (B) uncorrected distance (UC) method with 141-Cap (d) sequence alignment; and (C) uncorrected
distance method with 164-Cap alignment. x axis: A, ML distances; B and C, percentages; y axis: frequency.
D.-P. Zheng et al. / Virology 346 (2006) 312–323316
three distance ranges did not overlap, suggesting that NoVs
can be unambiguously classified into these three distinct
categories: strain (S), cluster (C), and genogroup (G). Some
minor peaks occurred in the C and G ranges, indicating the
diversity of NoV strains. The extension of the major peak of
G to the right represents the distances between the GV
genogroup (murine NoV) and the other genogroups, and the
minor peaks to the left represent the distances between the
GII and GIV genogroups. The highest diversity in the C
range was between strains in clusters GII/4 and GII/15; the
lowest was between strains in clusters GII/1 and GII/12,
which was close to the highest distance cutoff for S. In the S
range, the most diverse strains were among strains within
GI/5 cluster. Distances were then calculated with the
uncorrected method and plotted in the same way into the
histograms (Fig. 2B, using the same alignment as in Fig. 2A;
Fig. 2C, using the 164-sequence alignment with gaps). Both
demonstrated three clearly resolved and non-overlapping
peaks with very similar distribution patterns as indicated in
Fig. 2A. These consistent results further support the classi-
fication scheme defined with the Bayesian phylogenetic
analysis.
Defining distance ranges of NoV strains within and between
clusters and between genogroups
In our earlier study, we suggested definitions for genetic
cluster, genogroup and prototype, and reference strains (Ando
et al., 2000). Since limited numbers of complete capsid
sequences were available at that time, only 39 sequences of
NoV strains were analyzed. In this study, 164 capsid
sequences of NoV strains representing five genogroups were
chosen to investigate the diversity of NoVs and to establish
the criteria for classification. On the basis of the NoV
distance matrixes (data not shown) and the histogram
analyses above, we calculated the pairwise distance ranges
of NoV strains within clusters, between clusters, and between
genogroups (Tables 2 and 3). The maximum number in any
group of pairwise distance ranges did not overlap with the
minimum number in the next higher distance range group by
any of the methods used. This observation indicates statisti-
cally that no intermediate strains between clusters or between
genogroups were found in the window of the gene encoding
the major structural capsid protein. The results produced by
the uncorrected and the ML distance methods with different
types of sequence alignments were consistent, suggesting that
the pairwise distance ranges defined in Table 2 can be
proposed as standards for classification of NoV strains.
Differences among genogroups were further characterized
(Table 3). The human genogroups had the closest distances:
GIV and GII (41.88% and 44.91% in 141 and 164
alignments, respectively); while the murine genogroup, GV,
had the greatest distances from the other genogroups, GI–III
(58–61% in both alignments). These data all strongly support
the classification scheme defined using Bayesian phylogenetic
analysis.
Proposed standards for NoV nomenclature
Based on the phylogenetic relationships and the classifica-
tion scheme in the tree (Fig. 1), a maximum of 3 strain
sequences from each cluster (i.e., 1 prototype strain and up to 2
reference strains) were selected to construct a standard tree for
NoV nomenclature (Fig. 3). This figure, including 68
sequences, maintained the topology of the original tree (Fig.
1). All cluster branches in the tree were distinct from each other
and were supported with robust posterior probability values.
On the basis of the consistency of the topologies in both trees,
we propose the classification scheme described in this study as
standard nomenclature for NoVs: 29 genetic clusters are
classified in the 5 genogroups, 8 in GI, 17 in GII, 2 in G3,
and 1 each in G4 and G5. Among these, 5 clusters in GII (GII/
13–17) and 1 cluster in GI (GI/8) are newly defined or
described (Table 4). The standard for classification of a new
cluster would be a 15–45% pairwise distance difference based
on the complete capsid AA sequences (VP1) analyzed by the
uncorrected distance method. Strains with distances below this
range would be included with strains in the same cluster.
Strains with distance above this range might represent different
or new genogroups. Such outliers would require additional
molecular and possibly biological data to support any new
classification.
Characteristics of segmental capsid sequences of NoV in terms
of diversity and pairwise distance range
Because of the difficulty amplifying the entire capsid gene
of many strains due to their sequence diversities, various
segmental regions in ORF1 and ORF2 have been used as
shortcuts for diagnosis and genotyping (Ando et al., 2000;
Vinje´ et al., 2004). To explore statistically the molecular details
Table 2
Pairwise distance ranges among noroviruses compared with 3 different
sequence alignments
Sequence alignment Distance range between
Strains (S) Clusters (C) Genogroups (G)
141 Cap (d) ML 0–0.1235 0.1299–0.7941 0.9207–1.9474
141 Cap (d) UC 0–10.62 11.04–40.42 41.88–58.54
164 Cap UC 0–14.07 14.26–43.78 44.91–61.41
Cap (d): gaps in the AA sequence alignment were deleted.
ML: maximum likelihood; UC: uncorrected.
Table 3
Pairwise difference ranges between NoV genogroups (%) calculated with 2
different sequence alignments
G1 G2 G3 G4 G5
G1 48.54–55.21 45.62–52.29 48.75–53.75 55.62–58.33
G2 50.20–57.06 50.21–54.79 41.88–48.33 55.21–58.54
G3 47.57–53.94 52.07–56.89 52.50–54.38 56.25–58.12
G4 52.11–56.11 44.91–51.61 54.88–56.58 56.04
G5 58.14–60.74 58.17–61.41 57.74–59.68 58.56–58.75
Differences were calculated by using the uncorrected distance method with the
141 Capsid (d) AA sequence alignment (top right portion) and with 164 Capsid
AA sequence alignment (bottom left portion).
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of ORF2, we evaluated 5 overlapping (¨115 AA) segments
200 AA in length (each spanning from the N- to the C-
terminal) and three structural domains of S, P1, and P2
(Prasad et al., 1999) for strain diversity and distance range as
described above (Table 5). The least diversity in the 3 strain
categories (S, C, and G) was located in segment 1 and the S
domain, both corresponding to the 5V-end of ORF2; the
greatest diversity was distributed in segment 4 and the P2
domain, another corresponding region within ORF2. This
observation is consistent with the results of other investiga-
tions (Katayama et al., 2002; Prasad et al., 1999). However,
the pairwise distance ranges of NoVs in the S, C, and G
strain categories for all segments and domains overlapped,
except in segment 5, where they were similar to those in the
complete capsid protein: 0–18.18%, 19.23–52.20%, and
53.59–70.93% versus 0–14.07%, 14.26–43.78%, and
44.91–61.41%, respectively. These results suggest that, with
Fig. 3. Standard NoV classification tree proposed for nomenclature. Tree was made with the structural alignment of 68 NoV sequences (column gaps removed) by
using MrBayes program (Huelsenbeck et al., 2001). Tree topology was evaluated on the base of 1,000,000 generations. See Fig. 1 legend for format of sequence
names and country codes.
Table 4
Genogroups and clusters of NoV strains
Genogroup Host No. of sequences Clusters New clusters
G1 Human 30 8 1
G2 Human/Porcine 121 17 5
G3 Bovine 9 2
G4 Human 3 1
G5 Murine 1 1
Total 5 164 29 6
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the exception of segment 5, NoV strains may be difficult to
differentiate on the basis of analysis of segment or domain
sequences alone.
Discussion
The International Committee on Taxonomy of Viruses has
no guidelines for the classification of viruses below the species
level, and, to date, no consensus for the classification of NoVs
within genogroups has been reached (Green et al., 2000a; van
Regenmortel et al., 2000). Furthermore, no simple immuno-
logical or biological methods are available to characterize
human NoVs (e.g., serotypes); thus, sequence analysis has
become the method of choice. To establish a standard
classification system, we analyzed the phylogenetic relation-
ships of 164 entire capsid sequences of NoV, using four unique
approaches: (1) we selected only those strains with complete
ORF2 sequences because ORF2 encodes the major structural
protein that contains cell receptors and immunological deter-
minants that might correlate with viral serotypes or phenotypes,
and it is sufficiently long to allow proper differentiation
between strains; (2) we included all possible NoV sequences
from various hosts to present the true diversity of strains; (3)
we used structure-based AA sequence alignment because
phylogenetic outcomes are affected by the quality of sequence
alignments, and alignment based on capsid structures also
reflects more true homological relationships of the strains; and,
(4) we used a Bayesian phylogenetic method that can
efficiently handle a large number of sequences and produces
the best trees based on likelihood. With these criteria, we
defined a classification of NoVs with 29 genetic clusters, 8 in
G1, 17 in G2, 2 in G3, and 1 each in G4 and G5. This
phylogenetic scheme was statistically supported by pairwise
distance analysis and was used to standardize the classification
of NoVs. We also defined the ranges of pairwise distances for
strains within a cluster, between clusters, and between
genogroups, which provided clear criteria and a practical guide
for characterization and description of outbreak strains.
Five well-segregated clades were observed in the tree
generated from analysis of alignment of 141 sequences. These
represent the current five NoV genogroups (GI–GV) as
identified in other studies (Fankhauser et al., 2002; Green et
al., 1995; Karst et al., 2003; Oliver et al., 2003; Vinje´ and
Koopmans, 2000). Among them, clades GI and II are the two
largest genogroups and contain most of the diverse sequences
in the collection (8 and 17 clusters, respectively). These include
6 newly defined or described clusters: GI/8 in GI and GII/13–
17 in GII (Vinje´ et al., 2004). Three unresolved clusters of j, m,
and n in an earlier study were resolved and assigned clusters of
GII/13, GII/16, and GII/10 (Fankhauser et al., 2002). The GII/4
is the most active cluster and contains the strains that have
caused the most outbreaks worldwide since 1993, including the
most recent US outbreaks (on land and aboard cruise ships) and
national outbreaks in United Kingdom (Noel et al., 1999;
Vipond et al., 2004; Widdowson et al., 2004). Except for GII/
11, all sequences in GI and GII were from human viruses.
Another human genogroup, the newly defined GIV, to date
contains only 1 cluster (Fankhauser et al., 2002; Vinje´ et al.,
2004). Two other genogroups, GIII and GV, include strains
from cows and mice and have 2 and 1 clusters, respectively.
The murine strain, MNV-1, is the only NoV that grew
successfully in cell culture and in a small animal model (Karst
et al., 2003; Wobus et al., 2004). All together, 29 clusters in 5
genogroups were defined based on the tree topology shown in
Fig. 1.
To evaluate the robustness of this classification scheme, we
investigated the distributions of the pairwise distances between
strains, using the ML or uncorrected method with different
sequence alignments with or without gaps. All gave the same
results, with three clearly resolved peaks that did not overlap.
The 3-peak distribution pattern provides insight into the nature
of the evolution of NoVs and evidence that NoVs can be
further classified into 3 levels: strain (S), cluster (C), and
genogroup (G). The same three levels also exist in ‘‘Sapporo-
like viruses,’’ another genus within the Caliciviridae. However,
the diversity of ‘‘Sapporo-like viruses’’ was substantially less
than that for NoVs, with differences of 1–5%, 19–25%, and
49–55% for intra-cluster, inter-cluster, and inter-genogroup,
respectively (Schuffenecker et al., 2001).
The existence of the minor peaks around large peaks (Fig.
2A) further demonstrates the greater diversity of NoVs. None
of the distance distributions in major or minor peaks ranged
across the classification line within cluster S, between clusters
C, or between genogroups G. Therefore, the distance ranges of
S, C, and G were used as criteria to classify new strains, which
also extended our definitions for strains, clusters, and
genogroups (Ando et al., 2000). The results (Fig. 2) obtained
by using the three approaches provided parallel, consistent, and
confirmatory results, demonstrating that the phylogenetic
classification scheme of NoVs is well established and suited
for making a standard tree for nomenclature (Fig. 3). We
simplified the tree to include only one prototype (in bold) and
up to two reference sequences selected from each cluster of the
comprehensive tree and assigned consecutive numbers to the
clusters that corresponded to the order of submission of the
Table 5
Pairwise distance ranges of segments and structural domains
Window Location (AA) Strains Clusters Genogroups
Capsid 3–546 0–14.07 14.26–43.78 44.91–61.41
Segment
1 3–202 0–5.10 4.08–32.65 25.13–48.47
2 89–288 0–8.46 7.00–32.50 34.50–54.70
3 175–374 0–20.39 19.91–53.18 53.27–72.43
4 261–460 0–28.17 26.39–62.15 58.88–76.32
5 347–546 0–18.18 19.23–52.20 53.59–70.93
Domain
S 50–225 0–6.85 3.65–30.14 25.69–48.86
P1 226–278 0–14.12 13.02–42.60 44.58–65.88
406–520
P2 279–405 0–33.09 30.40–74.64 66.94–84.21
Pairwise distance ranges were calculated by using the uncorrected method with
164 NoV sequences based on sequence window setting. Segments 1–5: 200
AA each, overlapped by ¨115 AA, starting from N to C-terminal of capsid
protein (based on NV strain, M87661); structural domains (S, P1, P2) (Prasad
et al., 1999).
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prototype sequence to GenBank (Ando et al., 2000). Clearly,
the tree topologies were maintained, and all cluster branches
were supported by robust posterior probability values. We
propose the phylogenetic classification scheme of NoVs plus
the statistical measurements as guidelines for new NoV strain
classification and nomenclature. By using the uncorrected
distance method with untreated AA complete capsid sequences,
the difference ranges were 45.0–61.4% for genogroups, 14.3–
43.8% for clusters, and 0–14.1% for strains within a cluster.
The use of short conserved sequences has been successful for
establishing diagnoses of NoV infection, but it became
problematic for the classification or phylogenetic analysis
because the small fragments made some strains indistinguish-
able and generated inconsistent and confused classification
results. Strains with identical fragments were later found to be
distinct when the full capsid was sequenced. A study based on
the partial capsid N/S domain region defined 31 genotypes in GI
and GII (Kageyama et al., 2004). When compared with the
results of the entire capsid sequence analysis in this study,
excluding 7 genotypes (4 in GI: GI/11–14 and 3 in GII: GII/11,
15, 16) that could not be compared due to only partially
determined capsid sequences, 23 genotypes were found
belonging to 25 clusters (16 agreed with each other [5 in GI:
GI/1–4, 7 and 11 in GII: GII/1–10, 12]; 4 in GI [GI/5, 9 and GI/
6, 8] belonged to 2 clusters [GI/5 and GI/6]; 2 in GII [GII/13, 14]
were swapped; 1 [GI/10] had a different clustering number
[GI/8]), and 1, defined as GII/17 (Alphatron-related viruses),
was characterized as GIV in this and other studies (Fankhauser et
al., 2002; Karst et al., 2003; Vinje´ and Koopmans, 2000; Vinje´ et
al., 2004). The inconsistent classification results from partial
sequence analyses were attributed to the different conservation
rates along the genomic sequences (Table 5). Recombination
within the capsid (Rohayem et al., 2005) also affected the correct
classification. Therefore, we do not recommend using a partial
sequence to classify new NoV strains.
NoV sequences have great genetic diversity, and the hyper-
variable region is located in the capsid gene. Consistent with
the findings of others (Green et al., 1995, 2000b; Katayama et
al., 2002; Prasad et al., 1999; Vinje´ et al., 2000), we found that
the capsid sequences varied by up to 60% between the five
genogroups and up to 57% in human NoVs, a level of diversity
much higher than that seen for other plus single-stranded RNA
viruses, such as enteroviruses (polioviruses: ¨20% in nts;
Zheng et al., 1993) or respiratory viruses (rubella: ¨10% in
nts; Zheng et al., 2003), suggesting that the genogroups of NoV
might be individual species or serotypes. Because no neutral-
ization test is available for NoV serotyping, data on correlation
of phylogenetic and antigenic characterizations are needed to
support this hypothesis. The greater genetic diversity also
suggests that NoVs might evolve faster than other RNA
viruses, but the dynamic evolution of the virus remains
unknown. We recently observed that virus transmitted during
three outbreaks on a cruise ship in 18 days showed almost no
mutation changes in ORF2 (Zheng, D.P., unpublished data).
Nevertheless, an individual with chronic diarrhea shed viruses
that had 32 AA changes accumulated in ORF2 during 1 year
of illness (Nilsson et al., 2003). In addition to a higher
mutation rate, recombination also contributes to the diversity
and the evolution of RNA viruses. Human and bovine NoVs
are no exception, and recombination at the junction of ORF1/
2 and in ORF2 of human NoVs and in ORF1 of bovine
NoVs was observed (Han et al., 2004; Katayama et al., 2002;
Oliver et al., 2004; Rohayem et al., 2005; Vinje´ et al., 2000).
Recombination events may create new genotypes or species
and cause difficulty in strain classification because the
recombinants could be intermediates between genotypes or
species. So far, no intermediate strains have been identified
by capsid sequences analysis.
A recent study using the evolutionary trace method split the
phylogenetic tree of NoVs into 10 even partitions and then
grouped strains together that were nested in the same partition.
Using these settings, bovine GIII strains were suggested to
group with human GI strains and human GIV strains group
with those of GII (Chakravarty et al., 2005). Our data
demonstrate that NoV strains fall into 5 well segregated clades
consistent with the 5 distinct genogroups previously defined.
These 5 clades are statistically supported by our analysis of the
pairwise distance distribution. Furthermore, the statistical
differences in the ranges of pairwise distances that we observed
between strains, clusters, and genogroups were not continuous
and overlapping but were clearly divided, suggesting that they
might well have a biological basis. Other criteria (http://
www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/00.012.0.03.001.
htm) often used to classify viruses include host range, and,
unlike the results of Charavarty, our classification scheme
places the bovine GIII strains into its own distinct genogroup,
separate from the human GI strains. We also believe that the
evolutionary trace method which is good for identifying
conserved residues of genotypes or classes missed important
information on genetic diversity that is critical for understand-
ing molecular evolution and identifying epidemiologic links.
Setting cutoff values at partition P03 to classify norovirus
genogroups is quite arbitrary and does not reflect the clear
statistical and natural relationships of NoVs that we observed.
An added advantage of our approach is that, given any capsid
sequence, the investigators can immediately classify their strain
by genogroup, cluster, and strain after compared with those of
prototype viruses we defined in this study.
In summary, we used a unique approach to standardize a
classification scheme and provide clear criteria for NoV
nomenclature below the genus level. Supporting data from
biological or immunological characterization are not yet
available due to the lack of a cell culture system; however,
our results from phylogenetic analysis for genetic classification
are reliable because the characterization was carried out with
entire gene sequences of the major capsid protein, which
correlated with strain phenotypes or serotypes, and the genetic
groupings of G, C, and S were based statistically on their
pairwise distance ranges, which reflected the natural relation-
ships of NoVs. With rapid expansion of the number of
sequences of diverse NoVs, this system provides guidelines
for classifying new NoV strains while avoiding false classifica-
tions and confusion such as that generated from short
conserved sequences. It can also enable selection of represen-
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tative strains for preparation of virus-like particles for future
biological or immunological studies, for the evaluation of
diagnostic methods and results, and possibly for the study of
candidate strains for vaccine production.
Materials and methods
NoV capsid (VP1) AA sequences
For this study, we selected 164 sequences of NoV strains
(Table 1) that met the following criteria: the capsid gene
sequence was complete and unique and had no ambiguous
residues, with the exception of some prototype sequences
(shown in bold). Of these, 145 were obtained from GenBank
(submitted prior to Dec. 2003) by a BLAST search for
Norovirus (taxonomy ID: 142786) with a sequence length of
1400–8000 nucleotides (nts), and 19 were from strains that had
been newly sequenced at CDC using previously described
methods (Fankhauser et al., 2002), except that, for this study,
the primers were designed individually on the basis of each
strain’s sequences (data not shown). All nt sequences were
translated into AA sequences for analysis.
Structure-based alignments of NoV AA sequences
A structure-based alignment of 43 capsid protein sequences
was created based on the X-ray crystallographic structure of
Norwalk strain capsid protein (Protein Data Bank identifica-
tion, 1IHM) (Prasad et al., 1999) and other NoV capsid protein
structures that were predicted by use of the MODELER
program (INSIGHT II, version 2000.1, Accelrys Inc., San
Diego, CA), including repetitive refinement of spatially aligned
3D models until the root mean square deviation between the
model and 1IHM became 1.2 A˚ or less. To create the structure-
based alignment with all 164 sequences, the remaining 121 AA
sequences were grouped according to their homologies as
determined by a preliminary phylogenetic analysis. Each of
these sequences was then added and manually adjusted to the
spatially aligned 43 sequences based on their obvious
similarities.
Phylogenetic analysis
A preliminary phylogenetic analysis of the 164 sequences
was done using the Pileup program (Wisconsin Package,
version 10.3, Accelrys Inc., San Diego, CA) with the
uncorrected distance algorithm. The phylogenetic analyses of
structure-based alignments of 141 and 68 capsid sequences
were performed using the MrBayes program (version 3, http://
www.morphbank.ebc.uu.se/mrbayes/), a program for the
Bayesian inference of phylogeny based upon a quantity
called the posterior probability distribution of trees searched
by the Markov chain Monte Carlo algorithm (Huelsenbeck et
al., 2001). The input of the program (NEXUS file) includes a
character matrix (the structure-based sequence alignment) and
analysis settings (ngen = 1,000,000 [clustering generation
number], nchains = 4 [searching chain number], samplefreq =
500 [sample frequency], swapfreq = 2 [swapping frequency
number]). The best tree was collected from the pool of
1,000,000 tree generations, according to the highest likeli-
hood number, viewed with TreeView software (Page, 1996)
and edited with CorelDraw 10 (Corel Corporation, Ottawa,
Canada).
Pairwise distance calculation
Pairwise distances of AA sequences in the 164-sequence
alignment (with gaps) and in the 141-sequence alignment
(without gaps) were calculated using both uncorrected distance
(Wisconsin Package, version 10.3, Accelrys Inc., San Diego,
CA) and the maximum likelihood (ML) distance (Tree-Puzzle
5.0) (settings for quartet likelihood searching: puzzling step
[50,000], parameter estimates [exact], model of substitution
[auto, JTT], AA frequencies [estimate from data set], model of
rate heterogeneity [gamma distributed rates], gamma distribu-
tion parameter alpha [1.00], and number of gamma rate
categories [8]) (Schmidt et al., 2002). The distances were
sorted into three categories: S, the distances between strains
within clusters; C, the distances between strains across clusters;
and G, the distances between strains across genogroups,
according to the classification scheme obtained from the
phylogenetic analysis detailed above. These data were used
to generate histograms of the distributions of pairwise
distances.
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